Therapeutic Approach

Archive: March, 2016

Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update

LOS ANGELES (March 21, 2016) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutics that modulate the human gut microbiome to treat gastrointestinal diseases, today reported financial results and a business update for the fourth quarter and full year ended December 31, 2015. 2015 and Recent Operational […]

Leave Your Comments »

Ritter Pharmaceuticals Doses First Patient in Phase 2b/3 Trial of RP-G28 in Lactose Intolerance

LOS ANGELES (March 21, 2016) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutics that modulate the human gut microbiome to treat gastrointestinal diseases, today announced the dosing of the first patient in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance. Andrew […]

Leave Your Comments »

Ritter Pharmaceuticals Initiates Phase 2B/3 Clinical Trial of RP-G28 in Lactose Intolerance

LOS ANGELES (March 14, 2016) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutics that modulate the human gut microbiome to treat gastrointestinal diseases, today announced initiation of its Phase 2B/3 clinical trial of RP-G28, which has the potential to be the first FDA-approved treatment for lactose […]

Leave Your Comments »

Ritter Pharmaceuticals to Present at the 28th Annual ROTH Conference

LOS ANGELES (March 10, 2016) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutics that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that Michael Step, Chief Executive Officer, will present a corporate overview at the 28th Annual ROTH Conference on Tuesday, March 15, […]

Leave Your Comments »

Ritter Pharmaceuticals Featured in PharmaVOICE

  The Microbiome: A New Research Tool   http://www.pharmavoice.com/article/2016-03-microbiome/ Contributed by: Denise Myshko Our bodies are home to trillions of microbes, including bacteria, fungi, and viruses. These microbes are essential; they help digest food, produce certain vitamins, and regulate the immune system. Until recently, little was known about these microbes, but advances in DNA sequencing […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD